-
Aberrant Striatal Morphology: Impact on Therapeutic Efficacy in PD
… model, but did show some potential beneficial effects on dyskinesia. More analysis is needed to confirm these …
-
Michael J. Fox Foundation Announces Over $10 Million in Funding for Clinical and Pre-Clinical Parkinson’s Research
October 6, 2010
… Dr. Keywood will test a candidate drug that has alleviated dyskinesia in pre-clinical models of PD by targeting a …
-
New Drug FDA-Approved for Parkinson’s “Off” Time
October 16, 2019
… to levodopa/carbidopa. Common side effects may include dyskinesia (abnormal, involuntary movement), dizziness, …
-
Assessing a Novel Strategy for Noninvasive Stimulation of Dopamine-producing Neurons in Preclinical Models of Parkinson’s Disease
… and is often accompanied by long-term side effects, such as dyskinesias. When individuals in the advanced stages of PD …
-
Michael J. Fox
… Born in Canada, Michael J. Fox is an award-winning television and film actor whose … toward a cure for Parkinson's disease, he established The Michael J. Fox Foundation for Parkinson's Research. Today …
-
FDA Reviewing Four New Parkinson's Medications in 2024
July 18, 2024
… with times of significant symptoms and/or extra movement (dyskinesia) throughout the day. The pill aims to potentially …